Overview
We are seeking a dedicated and experienced Remote Triage Nurse (RN or LPN) to join our virtual care team. The Triage Nurse will provide patient assessments via phone or digital channels, determine the urgency of symptoms, and guide individuals to the appropriate level of care.
Key Responsibilities
Perform clinical assessments over the phone or secure messaging platforms using standardized triage protocols
Prioritize patient needs and direct them to emergency, urgent, or routine care as appropriate
Provide evidence-based health education and symptom management advice
Document all patient interactions clearly and accurately in the electronic health record (EHR)
Collaborate with physicians, nurse practitioners, and care coordinators to ensure continuity of care
Identify and act quickly in cases involving emergency symptoms or risk of harm
Required Qualifications
Current RN or LPN license in good standing (multi-state license preferred)
Minimum of 1 years of recent clinical experience (preferably in emergency, urgent care, or primary care)
Prior experience in telephone triage or telehealth is strongly preferred
Proficient with EHR systems and comfortable using virtual care technology
Strong communication, clinical judgment, and decision-making skills
Ability to work independently and maintain patient confidentiality at all times
Benefits
Competitive hourly pay ($68/hr)
You can work either full time or Part time.
Work-from-home flexibility, the working hours are also flexible, you are allowed to work a minimum of 10 hours and maximum of 40 hours weekly.
Paid training and continuing education opportunities
Health, dental, vision, and 401(k) (for eligible full-time roles)
Supportive and collaborative virtual care team
About Fate Therapeutics
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of programmed off-the-shelf cellular immunotherapies to patients.
To create better cell therapies, we have pioneered a therapeutic approach that we generally refer to as cell programming: we create and engineer human induced pluripotent stem cells (iPSCs) to incorporate novel synthetic controls of cell function; we generate a clonal master iPSC line for use as a renewable source of cell manufacture; and we direct the fate of the clonal master iPSC line to produce our cell therapy product candidate. Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, we believe our proprietary clonal master iPSC lines can be used to mass produce multiplexed-engineered, cellular immunotherapies which have off-the-shelf availability, can be combined and administered alone or with standard-of-care therapies, providing significant patient reach.
